Revital Mandil–Levin
Direktor/Vorstandsmitglied bei NEUROSENSE THERAPEUTICS LTD.
Vermögen: 30 808 $ am 31.05.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Alon Ben-Noon | M | 45 | 7 Jahre | |
| Christine Pellizzari | F | 56 | 3 Jahre | |
| Rachela Popovtzer | F | - |
Nanocarry Therapeutics Ltd.
 Nanocarry Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Nanocarry Therapeutics Ltd. is a company based in Nes-Ziona, Israel. Nanocarry is developing a new class of therapeutics using bioengineered nanoparticles to treat oncology indications and brain diseases. The Israeli company's proprietary "plug and play" approach allows for easy modification to deliver a wide array of biologics safely and effectively to the brain and beyond. Nanocarry's first products in development are for brain metastases of HER2+ breast cancer and non-small cell lung cancer. The company aims to extend the reach of biological therapeutics to the brain to tackle CNS diseases head-on, pioneering a multidisciplinary approach that overcomes the blood-brain barrier. The company was founded by Rachela Popovtzer, Oshra Betzer, and Revital Mandil-Levin, with Revital Mandil-Levin serving as the CEO since incorporation. | - |
| Cary Claiborne | M | 64 | 3 Jahre | |
| Caren Deardorf | F | 59 | 3 Jahre | |
| Oron Yacoby-Zeevi | M | 63 | 11 Jahre | |
| Mark Leuchtenberger | M | 67 | 3 Jahre | |
| Oshra Betzer | M | - |
Nanocarry Therapeutics Ltd.
Nanocarry Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Nanocarry Therapeutics Ltd. is a company based in Nes-Ziona, Israel. Nanocarry is developing a new class of therapeutics using bioengineered nanoparticles to treat oncology indications and brain diseases. The Israeli company's proprietary "plug and play" approach allows for easy modification to deliver a wide array of biologics safely and effectively to the brain and beyond. Nanocarry's first products in development are for brain metastases of HER2+ breast cancer and non-small cell lung cancer. The company aims to extend the reach of biological therapeutics to the brain to tackle CNS diseases head-on, pioneering a multidisciplinary approach that overcomes the blood-brain barrier. The company was founded by Rachela Popovtzer, Oshra Betzer, and Revital Mandil-Levin, with Revital Mandil-Levin serving as the CEO since incorporation. | - |
| Shiran Zimri | M | - | 4 Jahre | |
| Anat Nahmany | F | - | 8 Jahre | |
| Irit Shefer | F | - | 2 Jahre | |
| Diana Shtossel | F | - | 2 Jahre | |
| Nedira Salzman-Frenkel. | F | - | 2 Jahre | |
| Ferenc Tracik | M | 60 | 3 Jahre | |
| Mikio Himizu | M | - | 7 Jahre | |
| Ziva Mesika | F | 60 | 8 Jahre | |
| Omri Amirav-Drory | M | - |
Nanocarry Therapeutics Ltd.
Nanocarry Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Nanocarry Therapeutics Ltd. is a company based in Nes-Ziona, Israel. Nanocarry is developing a new class of therapeutics using bioengineered nanoparticles to treat oncology indications and brain diseases. The Israeli company's proprietary "plug and play" approach allows for easy modification to deliver a wide array of biologics safely and effectively to the brain and beyond. Nanocarry's first products in development are for brain metastases of HER2+ breast cancer and non-small cell lung cancer. The company aims to extend the reach of biological therapeutics to the brain to tackle CNS diseases head-on, pioneering a multidisciplinary approach that overcomes the blood-brain barrier. The company was founded by Rachela Popovtzer, Oshra Betzer, and Revital Mandil-Levin, with Revital Mandil-Levin serving as the CEO since incorporation. | 3 Jahre |
| Or Eisenberg | M | 43 | 3 Jahre | |
| Hagit Binder | F | - | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Robert Taub | M | 78 | 10 Jahre | |
| Alon Yaar | M | 59 | - | |
| Larry Ellberger | M | 76 | 3 Jahre | |
| Alla Felder | F | 51 | - | |
| Jonathan Kalman | M | 66 | - | |
| Michal Roytman | M | 39 | 1 Jahre | |
| Wolfgang Ruttenstorfer | M | 73 | 1 Jahre | |
| Ofra Levy-Hacham | M | 59 |
HealOr Ltd.
 HealOr Ltd. Pharmaceuticals: MajorHealth Technology HealOr Ltd. develops and commercializes proprietary biochemical regulatory therapeutics impacting skin cells properties for the purpose of treating various skin pathologies. Its leading drug, HO/03/03, is currently undergoing Phase II/III clinical trials in the United States and India. The company is also establishing a first-in-class therapeutic pipeline for additional skin pathologies such as chronic and acute wounds, dry skin, acne, psoriasis, and others. HealOr was founded by Tamar Tennenbaum in 2002 and is headquartered in Rechovot, Israel. | 5 Jahre |
| Sharon Cohen-Vered | M | 57 | 10 Jahre | |
| Andrew Udell | M | 54 | 1 Jahre | |
| Roy Golan | M | 50 | 4 Jahre | |
| Tami Yardeni | F | 52 | 2 Jahre | |
| Tami Rachmilewitz | M | 54 | 2 Jahre | |
| Elana Gazal | M | 49 | 5 Jahre | |
| Yael Barak | F | - | - |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Israel | 34 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Revital Mandil–Levin
- Persönliches Netzwerk